邁越科技(02501.HK)訂立戰略合作 在泰銷售AI翻譯眼鏡
邁越科技(02501.HK)公布,與Yong Sheng訂立不具法律約束力的戰略合作協議,據此,雙方同意在泰國推廣人工智能「AI」應用及產品,期限三年。初始階段,Yong Sheng將向公司購買1,000副邁越AI翻譯眼鏡,採購資金來源為泰國政府資金;於第二階段,公司可應要求考慮授予Yong Sheng於泰國獨家分銷該翻譯眼鏡的權利。
Yong Sheng是由上海市廣西商會與一名泰國王室成員透過合資企業成立的跨國商業服務供應商。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.